Physician profile
Caryn Hollander
NPI 1245492644
$1,742.09
in general payments reported to CMS, 2019-2025
26 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $292 · 2021: $346 · 2022: $606 · 2023: $65.55 · 2024: $34.25 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $247.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $439.68 | 2019-2022 | |
| Myovant Sciences INC. | $132.29 | 2021-2022 | |
| Hologic Sales and Service, LLC | $128.85 | 2019-2022 | |
| Momentis Surgical INC. | $123.00 | 2022 | |
| Daiichi Sankyo INC. | $118.15 | 2022 | |
| Exeltis, USA INC. | $73.87 | 2020-2022 | |
| Bioventus LLC | $73.46 | 2023-2025 | Supartz Fx Sodium Hyaluronate, Supartz Fx Sodium Hyaluronate, Durolane |
| Therapeuticsmd, INC. | $60.51 | 2020-2021 | |
| Minerva Surgical, INC | $59.70 | 2019-2021 | |
| Organon LLC | $59.09 | 2022-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $56.20 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $49.40 | 2024-2025 | Menopur, Euflexxa |
| Aspira Women'S Health INC | $48.77 | 2022 | |
| Sumitomo Pharma America, INC. | $42.36 | 2025 | Gemtesa |
| Covidien LP | $39.97 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $36.82 | 2019-2022 | |
| Lupin INC. | $30.46 | 2019 | |
| Coopersurgical, INC. | $29.85 | 2019 | |
| Amag Pharmaceuticals, INC. | $27.01 | 2019-2020 | |
| Fidia Pharma USA INC. | $21.22 | 2023 | Hyalgan |
| Avanos Medical | $19.50 | 2023 | Coolief* Cooled Radiofrequency |
| Evofem Biosciences, INC. | $17.68 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.08 | 2019 | |
| Millicent US INC | $13.93 | 2025 | Femlyv |
| Allergan, INC. | $13.87 | 2020 | |
| Avion Pharmaceuticals | $12.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caryn Hollander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.